[go: up one dir, main page]

DE69029657D1 - Menschliches cytokin, interleukin-9 - Google Patents

Menschliches cytokin, interleukin-9

Info

Publication number
DE69029657D1
DE69029657D1 DE69029657T DE69029657T DE69029657D1 DE 69029657 D1 DE69029657 D1 DE 69029657D1 DE 69029657 T DE69029657 T DE 69029657T DE 69029657 T DE69029657 T DE 69029657T DE 69029657 D1 DE69029657 D1 DE 69029657D1
Authority
DE
Germany
Prior art keywords
interleukin
human
cytokin
protein
encode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69029657T
Other languages
English (en)
Other versions
DE69029657T2 (de
Inventor
Yu-Chung Yang
Agnes Ciarletta
Susan Ricciardi
Steven Clark
Robert Donahue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Cancer Research
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Application granted granted Critical
Publication of DE69029657D1 publication Critical patent/DE69029657D1/de
Publication of DE69029657T2 publication Critical patent/DE69029657T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5425—IL-9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69029657T 1989-05-23 1990-05-18 Menschliches cytokin, interleukin-9 Expired - Lifetime DE69029657T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35603389A 1989-05-23 1989-05-23
US07/515,308 US5580753A (en) 1989-05-23 1990-04-27 DNA encoding the human cytokine, interleukin-9
PCT/US1990/002830 WO1990014432A1 (en) 1989-05-23 1990-05-18 A human cytokine, interleukin-9

Publications (2)

Publication Number Publication Date
DE69029657D1 true DE69029657D1 (de) 1997-02-20
DE69029657T2 DE69029657T2 (de) 1997-08-07

Family

ID=26999092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029657T Expired - Lifetime DE69029657T2 (de) 1989-05-23 1990-05-18 Menschliches cytokin, interleukin-9

Country Status (10)

Country Link
US (2) US5580753A (de)
EP (1) EP0473724B1 (de)
JP (1) JP2914393B2 (de)
AT (1) ATE147436T1 (de)
AU (1) AU637620B2 (de)
CA (1) CA2056997C (de)
DE (1) DE69029657T2 (de)
DK (1) DK0473724T3 (de)
ES (1) ES2099096T3 (de)
WO (1) WO1990014432A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
US5132109A (en) * 1990-10-05 1992-07-21 Ludwig Institute For Cancer Research Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof
US5925750A (en) * 1990-10-19 1999-07-20 Institute National De La Sante Et De La Recherche Medicale (Inserm) Nucleic acid encoding polypeptide of a growth factor receptor family
US5728819A (en) * 1996-08-02 1998-03-17 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5654173A (en) * 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5708157A (en) * 1996-07-26 1998-01-13 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5985602A (en) * 1996-08-14 1999-11-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5723315A (en) * 1996-08-23 1998-03-03 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5945302A (en) * 1996-04-05 1999-08-31 Genetics Institute, Inc. Polynucleotides encoding secreted proteins
US5965388A (en) * 1996-07-09 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5908839A (en) 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
US6509313B1 (en) * 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
WO1998001469A2 (en) * 1996-06-19 1998-01-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998001552A2 (en) * 1996-07-09 1998-01-15 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998004695A1 (en) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU3890897A (en) * 1996-07-26 1998-02-20 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998004696A1 (en) * 1996-07-26 1998-02-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
JP2002516563A (ja) * 1996-08-02 2002-06-04 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
CA2263192A1 (en) * 1996-08-23 1998-02-26 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5830454A (en) * 1996-08-30 1998-11-03 Ludwig Institute For Cancer Research Method for treating cell mediated autoimmune disorders using interleukin-9
WO1998014576A2 (en) * 1996-10-04 1998-04-09 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998014470A2 (en) * 1996-10-04 1998-04-09 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU4670297A (en) * 1996-10-04 1998-04-24 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998017687A2 (en) * 1996-10-25 1998-04-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2241911A1 (en) * 1996-11-01 1998-05-14 Genetics Institute, Inc. Secreted proteins
AU4077697A (en) * 1996-11-06 1998-05-29 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998021332A2 (en) * 1996-11-15 1998-05-22 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
WO1998024904A2 (en) 1996-12-02 1998-06-11 Magainin Pharmaceuticals Inc. Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders
JP2002512503A (ja) * 1996-12-06 2002-04-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌蛋白およびそれらをコードするポリヌクレオチド
WO1998027997A1 (en) * 1996-12-20 1998-07-02 Magainin Pharmaceuticals Inc. A method for diagnosis and treatment of inflammatory bowel diseases including crohn's disease and chronic ulcerative colitis
WO1998030695A2 (en) * 1997-01-09 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2278104A1 (en) * 1997-01-13 1998-07-16 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU6031398A (en) * 1997-01-21 1998-08-07 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
WO1998031800A2 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Human proteins
WO1998032853A2 (en) * 1997-01-24 1998-07-30 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5965397A (en) * 1997-01-31 1999-10-12 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
AU6337398A (en) * 1997-02-24 1998-09-09 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP1352962A1 (de) * 1997-03-07 2003-10-15 Human Genome Sciences, Inc. 186 humane sekretierte Proteine
US7053190B2 (en) 1997-03-07 2006-05-30 Human Genome Sciences, Inc. Secreted protein HRGDF73
CA2283299A1 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
US6420526B1 (en) 1997-03-07 2002-07-16 Human Genome Sciences, Inc. 186 human secreted proteins
CA2284131A1 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 70 human secreted proteins
US6878687B1 (en) 1997-03-07 2005-04-12 Human Genome Sciences, Inc. Protein HMAAD57
US5976837A (en) * 1997-03-14 1999-11-02 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
CA2284550A1 (en) * 1997-03-21 1998-10-01 Human Genome Sciences, Inc. 87 human secreted proteins
WO1998045437A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
JP2001519667A (ja) * 1997-04-10 2001-10-23 ジェネティックス・インスチチュート・インコーポレーテッド 分泌発現配列タグ（ｓＥＳＴｓ）
WO1998045435A2 (en) * 1997-04-10 1998-10-15 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
CA2295474A1 (en) * 1997-07-08 1999-01-21 Human Genome Sciences, Inc. 123 human secreted proteins
EP1032838A4 (de) * 1997-11-07 2003-01-29 Human Genome Sciences Inc 125 menschliche sekretierte proteine
US6548633B1 (en) 1998-12-22 2003-04-15 Genset, S.A. Complementary DNA's encoding proteins with signal peptides
EP1220865A4 (de) * 1999-09-27 2003-04-02 Human Genome Sciences Inc 43 human-sekretierte proteine
CA2388914A1 (en) * 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 15 human secreted proteins
AU1473801A (en) * 1999-11-12 2001-06-06 Human Genome Sciences, Inc. 6 human secreted proteins
EP1401497B1 (de) 2001-06-08 2012-01-11 Genaera Corporation Verfahren zur modulation von il-13

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9

Also Published As

Publication number Publication date
EP0473724B1 (de) 1997-01-08
DE69029657T2 (de) 1997-08-07
JP2914393B2 (ja) 1999-06-28
AU5928990A (en) 1990-12-18
US5734037A (en) 1998-03-31
ES2099096T3 (es) 1997-05-16
JPH04506006A (ja) 1992-10-22
AU637620B2 (en) 1993-06-03
ATE147436T1 (de) 1997-01-15
CA2056997A1 (en) 1990-11-24
EP0473724A1 (de) 1992-03-11
CA2056997C (en) 2001-01-30
WO1990014432A1 (en) 1990-11-29
US5580753A (en) 1996-12-03
DK0473724T3 (da) 1997-04-14

Similar Documents

Publication Publication Date Title
DE69029657D1 (de) Menschliches cytokin, interleukin-9
DE69636147D1 (de) Verfahren zur herstellung von phosphorothioat-oligomeren
DK0409472T3 (da) Knoglemorfogenetisk protein
DE69739996D1 (de) Methoden und Zusammensetzungen zur Herstellung von Polypeptiden
ATE169335T1 (de) Zusammensetzungen und verfahren zur anregung des wachstums und der differenzierung von megakaryozyten
RU95115239A (ru) Аналог эритропоэтина
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
DE69224511D1 (de) Verfahren zur Herstellung von Kollagenfasern
DE59002803D1 (de) Verfahren zur Herstellung von natürlichem Vanillin.
DE68919246D1 (de) Verfahren zur Herstellung von Aminosäuren.
EP0205475A4 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
SE8801701D0 (sv) Production technology based on enzymic method
DE3869230D1 (de) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet, loesung, enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin.
ATE113982T1 (de) Verzweigungsenzym und dessen verwendung.
ATE64154T1 (de) Verfahren zur herstellung von l-carnitin auf mikrobiologischem weg.
DE69728415D1 (de) Produkte des keratinocyten-wachstumsfaktors 2 (kgf-2)
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
DK87190A (da) Fremgangsmaade til at regulere plantevaekst under anvendelse af svovlholdige organiske syrer
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
DE68926922D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
ATE353368T1 (de) Verfahren zur herstellung verzweigtkettiger fettsäuren mittels genetisch modifizierter pflanzen
ATE85612T1 (de) Verbessertes verfahren zur katalytischen hydrierung von dahnp und zur herstellung von dafhp.
ATE187738T1 (de) Verfahren zur identifizierung und herstellung von bindungsstellen aufeinanderwirkender proteine
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: LUDWIG INSTITUTE FOR CANCER RESEARCH, NEW YORK, N.

8364 No opposition during term of opposition